AnalystBook Research · Company Intelligence

Bain Capital Specialty Finance, Inc.

BCSFNYSE

Built from Bain Capital Specialty Finance, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Bain Capital Specialty Finance had lower net income, better cash from ops, higher dividends, and higher debt.

The read at a glance✓ Audited against SEC data
  • Business mixExternally managed BDCNote
  • ProfitabilityNet income fell 17.3%Watch
  • CashCash from ops turned positiveOK
  • DividendsDividends rose 27.6%OK
  • LeverageDebt rose 5.8%Watch
  • Insiders1 purchase / 0 salesOK
  • AccountingNo current forensic screen in bundleNote

Business

Bain Capital Specialty Finance is an externally managed BDC focused on senior middle-market lending opportunities across North America, Europe, Australia, and other markets.

Leadership changes

From Bain Capital Specialty Finance, Inc.'s own filings, the day they're filed.

  • Sabrina Rusnak-Carlson · General Counsel · departureeff. 2025-11-05
  • Jessica Yeager · President · departureeff. 2025-06-30
  • Katherine Schneider · Director · appointmenteff. 2025-04-28

Latest filings

  • 8-K · Company announcement2026-08-10
  • 10-Q · Quarterly report2026-08-10
  • 8-K · Company announcement2026-07-31
  • 8-K · Company announcement2026-07-23
  • 8-K · Company announcement2026-05-22
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Bain Capital Specialty Finance, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.